AI assistant
Minerva Neurosciences, Inc. — Director's Dealing 2018
Feb 3, 2018
35086_dirs_2018-02-02_2265fbc0-ca76-46c7-a218-0aac54abe9c4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2018-01-31
Reporting Person: Beer Marc D (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-01-31 | Stock Option (Right to Buy) | $9.49 | D | 80356 | Disposed | 2023-12-19 | Common Stock (80356) | Direct |
| 2018-01-31 | Stock Option (Right to Buy) | $9.49 | A | 80356 | Acquired | 2020-01-31 | Common Stock (80356) | Direct |
| 2018-01-31 | Stock Option (Right to Buy) | $6.00 | D | 127513 | Disposed | 2024-06-29 | Common Stock (127513) | Direct |
| 2018-01-31 | Stock Option (Right to Buy) | $6.00 | A | 127513 | Acquired | 2020-01-31 | Common Stock (127513) | Direct |
| 2018-01-31 | Stock Option (Right to Buy) | $4.34 | D | 7500 | Disposed | 2025-02-01 | Common Stock (7500) | Direct |
| 2018-01-31 | Stock Option (Right to Buy) | $4.34 | A | 7500 | Acquired | 2020-01-31 | Common Stock (7500) | Direct |
| 2018-01-31 | Stock Option (Right to Buy) | $10.20 | D | 12500 | Disposed | 2026-06-15 | Common Stock (12500) | Direct |
| 2018-01-31 | Stock Option (Right to Buy) | $10.20 | A | 12500 | Acquired | 2020-01-31 | Common Stock (12500) | Direct |
| 2018-01-31 | Stock Option (Right to Buy) | $10.00 | D | 12500 | Disposed | 2027-05-31 | Common Stock (12500) | Direct |
| 2018-01-31 | Stock Option (Right to Buy) | $10.00 | A | 12500 | Acquired | 2020-01-31 | Common Stock (12500) | Direct |
Footnotes
F1: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 20, 2013 and is fully vested.
F2: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 30, 2014 and is fully vested.
F3: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on February 2, 2015 and is fully vested.
F4: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 16, 2016 and is fully vested.
F5: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the
grant of a replacement option. The option was originally granted on June 1, 2017 and provides for vesting in four equal quarterly installments at
a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 1, 2017
and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee
director as of such vesting date.